Show simple item record

dc.contributor.authorSaeed, A.
dc.contributor.authorBentzen, S.M.
dc.contributor.authorMishra, M.V.
dc.date.accessioned2022-04-06T15:21:45Z
dc.date.available2022-04-06T15:21:45Z
dc.date.issued2021-11
dc.identifier.urihttp://hdl.handle.net/10713/18478
dc.description.abstractLymphopenia is a known toxicity of chemotherapy and radiation therapy (RT), part of the standard treatment for glioblastoma (GBM). Given the immune system's role in cancer control and general health, a number of single-institution studies have examined the association between treatment-related lymphopenia and survival outcomes of GBM patients. We performed a systematic review and pooled analysis to evaluate the association between lymphopenia and overall survival (OS) for GBM patients undergoing chemoRT.en_US
dc.description.urihttps://doi.org/10.1016/j.ijrobp.2021.07.1598en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofInternational Journal of Radiation Oncology - Biology - Physicsen_US
dc.rightsCopyright © 2021 Published by Elsevier Inc.en_US
dc.rights.urihttps://www.elsevier.com/tdm/userlicense/1.0/
dc.titleSystematic Review and Pooled Analysis of the Impact of Treatment-Induced Lymphopenia on Survival of Glioblastoma Patientsen_US
dc.typeAbstracten_US
dc.identifier.doi10.1016/j.ijrobp.2021.07.1598
dc.source.journaltitleInternational Journal of Radiation Oncology*Biology*Physics
dc.source.volume111
dc.source.issue3
dc.source.beginpagee598


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record